Delos Pharmaceuticals Company
Delos Pharmaceuticals, Inc. discovers and develops novel polyketide-based therapies to treat chronic disease. The company focuses on novel biological mechanisms that can be used to treat aging-related disease by addressing the basis for disease initiation and progression, such as oxidative, cellular, and environmental stress. Delos Pharmaceuticals, Inc. was incorporated in 2012 and is based in Novato, California.
Technology:
NeuroTech
Industry:
Biopharma, Pharmaceutical
Headquarters:
California, Kentucky, United States
Founded Date:
2012-01-01
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
3
Total Funding:
Â¥70M
Last Funding Type:
Seed
Register and Claim Ownership